| Gene symbol | CD40LG | Synonyms | CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD40 ligand | ||||
| GTO ID | GTC1252 |
| Trial ID | NCT00328887 |
| Disease | Esophageal Cancer |
| Altered gene | CD40LG |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdcuCD40L |
| Phase | Phase1 |
| Recruitment status | Withdrawn |
| Title | Phase I, Initial Safety/Toxicity Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdCUCD40L) to Patients With Stage III or IV Esophageal Carcinoma |
| Year | 2006 |
| Country | United States |
| Company sponsor | Weill Medical College of Cornell University |
| Other ID(s) | 0011004683|5 R01 CA10198-02 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||
|
|||||||